Primary sclerosing cholangitis - Diagnosis and treatment - Mayo Clinic
An Atypical Presentation of Diabetic Myonecrosis - ScienceDirect
IJMS | Free Full-Text | Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors | HTML
Clinical Practice Guidelines For The Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored By American Association of Clinical Endocrinologists/American College of ...
Cancers | Free Full-Text | The Alliance AMBUSH Trial: Rationale and Design | HTML
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials - The Lancet
American Society for Clinical Pharmacology and Therapeutics - 2022 - Clinical Pharmacology & Therapeutics - Wiley Online Library
Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo‐controlled study - Kelly - 2013 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
PDF) Mayo Clinic Gastroenterology and Hepatology Board Review booksmedicos | Daniela Rodriguez - Academia.edu
33-Year-Old Woman With Marked Eosinophilia
Pharmacogenovigilance: a pharmacogenomics pharmacovigilance program | Pharmacogenomics
Frontiers | Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD
Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney Disease | American Society of Nephrology
PDF) Nelarabine Associated Myotoxicity and Rhabdomyolysis
Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases | Nature Reviews Nephrology
Gout (Gouty Arthritis) Risk Factors, Diagnosis and Treatment
Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of ...
Treatment prospects for autosomal-dominant polycystic kidney disease - Kidney International
Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease | American Journal of Physiology-Renal Physiology
Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease | SpringerLink
Statin Toxicity | Circulation Research
